Pediatric Renal Cancer/ Childhood Kidney Cancer (Wilms): Surveillance and Follow-up Guidelines (Standard and High-Risk Pediatric Renal Tumor)

Wilms Cancer Foundation

23 May 2020

Cancer, Childhood Cancer, Pediatric Cancer, Pediatric Renal Cancer, Renal Cancer, Kidney Cancer, Renal Cancer, Childhood Kidney Cancer, Childhood Cancer, Oncology, Pediatric Oncology, Pediatric Renal Oncology, Nephroblastoma, Wilms, Wilms Tumor, Wilms Tumour, Wilms Cancer Foundation, Wilms Foundation, WCF, Global Initiative for Childhood Cancer, GICC, World Health Organization, WHO,

The following information forms part of the Wilms Cancer Foundation's (WCF) wider comprehensive “Briefing Series” on; ‘Wilms tumor’. The series is designed to provide educational information, at multiple levels, to key stakeholder groups including; children, families, caregivers, survivors, healthcare providers, administrators and government.

 

Briefing Series 6.1a

Pediatric Renal Cancer/ Childhood Kidney Cancer (Wilms): Surveillance and Follow-up Guidelines (Standard and High-Risk Pediatric Renal Tumor)

 

​This briefing provides a clear overview of post-treatment surveillance and follow-up care for pediatric renal cancer, specifically Wilms tumor. It outlines the purpose and objectives of ongoing monitoring, explains key definitions, and distinguishes between standard - and high-risk follow-up protocols. Designed to support caregivers and stakeholders, the document offers practical guidance on how long-term care is structured to detect recurrence early and ensure the best possible outcomes for children.

 

​​Key Highlights include: ​

a) Objectives of Surveillance;

b) Definitions. ​

 

For further information please contact the Wilms Cancer Foundation (WCF):

email: info@WilmsFoundation.org

Web: www.WilmsFoundation.org

 

The Wilms Cancer Foundation (WCF), is an international charitable organization, that supports and represents the needs of children, families and healthcare organizations affected by the pediatric renal cancer (childhood kidney cancer) nephroblastoma commonly known as ‘Wilms’. An official partner (Non-State Actor for the WHO) the organizations mission is to support children, families and healthcare providers who are tackling the disease on a daily basis through the establishment of an international program of awareness, education, advocacy, early detection and treatment to improve the quality of life of those diagnosed with the disease and reduce mortality rates.  This Wilms Cancer Foundation (WCF) guide is for educational purposes only and is released as part of the World Health Organizations (WHO) Global initiative for Childhood Cancer (GICC). It is based on international pediatric oncology standards in Canada, the United States and Europe.